ALX Oncology Holdings Inc.
ALXO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$22,144 | -$25,949 | -$30,754 | -$29,163 |
| Dep. & Amort. | $153 | $191 | $211 | $214 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,521 | $0 | $5,216 | $5,858 |
| Change in WC | $2,124 | -$3,172 | $645 | -$8,760 |
| Other Non-Cash | $253 | $5,524 | $19 | -$195 |
| Operating Cash Flow | -$17,093 | -$23,406 | -$24,663 | -$32,046 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$56 | -$47 | -$60 | -$60 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$4,442 | -$25,402 | -$15,775 | -$4,444 |
| Inv. Sales/Matur. | $25,890 | $47,765 | $43,480 | $37,687 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $21,392 | $22,316 | $27,645 | $33,183 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$160 | -$237 | -$307 | -$76 |
| Stock Issued | $0 | $15 | $372 | -$29,302 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $0 | $0 | $29,706 |
| Financing Cash Flow | -$159 | -$222 | $65 | $328 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4,140 | -$1,312 | $3,047 | $1,465 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $19,368 | $20,614 | $17,633 | $16,168 |
| End Cash | $23,508 | $19,302 | $20,680 | $17,633 |
| Free Cash Flow | -$17,149 | -$23,453 | -$24,723 | -$32,106 |